Clinical Trial Update: A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study) [Phase 2, Phase 3]

View source ↗

Summary

The AZTOUND study is evaluating ASTX030 (azacitidine and cedazuridine) alone or in combination with venetoclax in myeloid neoplasms including myelodysplastic sy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• ASTX030 (Azacitidine and Cedazuridine) (Azacitidine and Cedazuridine)
• Venetoclax (venetoclax)

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Myelodysplastic Syndromes, Acute Myeloid Leukemia | Phase 2, Phase 3 | Status: RECRUITING